Advertisement

Topics

A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone

2014-08-27 03:48:11 | BioPortfolio

Summary

To compare the effectiveness of a 90-day Copaxone® adherence enhancement program for a sample of MS patients who are at high risk of nonadherence and receive support from Shared Solutions® and their MS Center versus those who receive support only from Shared Solutions®.

Description

An Open Label, Prospective Parallel Cohort Design. Participants will be assigned to one of two conditions:

CONDITION A: Shared Solutions® CONDITION B: Shared Solutions® & MS Center Partnership

Study Design

Allocation: Non-Randomized, Control: Active Control, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Conditions

Multiple Sclerosis

Intervention

Shared Solutions® plus MS Center v. Shared Solutions®

Location

UAMS
Little Rock
Arkansas
United States
72205

Status

Completed

Source

Teva Pharmaceutical Industries

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:48:11-0400

Clinical Trials [1865 Associated Clinical Trials listed on BioPortfolio]

Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness

Obesity is increasing at an alarming rate in patients with schizophrenia, possibly in association with the increased use of atypical antipsychotics. In order to address the weight and meta...

TOnicity of Perioperative Maintenance SoluTions

Prospective randomized double blind phase IV trial studying the efficacy and safety of the tonicity of two different perioperative maintenance solutions: an isotonic solution containing Na...

Shared Care for Patients With Type 2 Diabetes Across the Primary and Secondary Health Care Sector

The aim of the study is to test the effect of a new shared care model for type 2 diabetes care and compare it with a standardized care management program in a specialized hospital-based ou...

Shared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder

The investigators hypothesize that implementation of a shared decision making care plan for prophylactic treatment will help therapeutic adherence of bipolar patients. They also anticipate...

pH Imaging in Multiple Sclerosis

Twenty subjects (10 patients and 10 age-matched control volunteers) will be recruited for this study. MRI scans will take place on a 3T MRI Scanner (Skyra or Prisma, Siemens Medical Soluti...

PubMed Articles [11340 Associated PubMed Articles listed on BioPortfolio]

Characterization of the first symptoms of multiple sclerosis in a Brazilian center: cross-sectional study.

Multiple sclerosis (MS) is a chronic, immune-mediated and degenerative central nervous system (CNS) disease with well-established diagnostic criteria. Treatment can modify the course of the disease. T...

Shared Decision Making in Australia in 2017.

Shared Decision Making (SDM) is now firmly established within national clinical standards for accrediting hospitals, day procedure services, public dental services and medical education in Australia, ...

Sharing post-AML consolidation supportive therapy with local centers reduces patient travel burden without compromising outcomes.

Acute myeloid leukemia (AML) is frequently treated with induction and consolidation chemotherapy. Consolidation chemotherapy can be delivered on an ambulatory basis, requiring some patients to travel ...

Shared decision-making in medication management: development of a training intervention.

Shared decision-making is a collaborative process in which clinicians and patients make treatment decisions together. Although it is considered essential to patient-centred care, the adoption of share...

Strategic Plan for Maximizing Shared Savings in Accountable Care Organizations.

One of the major benefits to a provider beginning or joining an accountable care organization (ACO) is the potential for achieving shared savings from the Medicare Shared Savings Program. This essay p...

Medical and Biotech [MESH] Definitions

Sterile solutions, essentially free from foreign particles and suitably compounded and dispensed, for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. (From Dorland, 27th ed)

Beliefs and values shared by all members of the organization. These shared values are reflected in the day to day operations of the organization.

Solutions used to store organs and minimize tissue damage, particularly while awaiting implantation.

An organization of insurers or reinsurers through which particular types of risk are shared or pooled. The risk of high loss by a particular insurance company is transferred to the group as a whole (the insurance pool) with premiums, losses, and expenses shared in agreed amounts.

Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery.

More From BioPortfolio on "A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Searches Linking to this Trial